Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Budesonide recalled?

Yes — there is an active recall. 4 ongoing FDA recalls mention Budesonide (22 total). Check the affected lots below.

Most common reason: cGMP deviation (7 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Budesonide. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Budesonide recalls in 2026

1 initiated in 2026, 22 in total — newest first
Class II · Moderate risk

Budesonide Inhalation Suspension

Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the ampoule solution

Ongoing Particulate / foreign matter Sun Pharmaceutical Industries INC NDC 47335-633-49 D-0607-2026
Class II · Moderate risk

Budesonide 0.4mg

Lack of Processing Controls

Terminated cGMP deviation Integrated Health Concepts Inc. dba Conversio Health D-0508-2020
Class II · Moderate risk

c-Budesonide 0.6MG capsules

Penicillin Cross Contamination - Possible presence of penicillin in bulk budesonide powder used to compound prescription nasal rinse/nebulizer capsules.

Terminated Cross-contamination Solutions Rx Pharmacy D-0385-2016
Class II · Moderate risk

Budesonide active pharmaceutical ingredient packaged in varying…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-550-2015
Class III · Low risk

Budesonide Capsules

Failed Dissolution Specifications: Routine stability testing at the 12-month interval yielded an out-of-specification (OOS) result for dissolution testing.

Terminated Dissolution failure Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 51079-020-03 D-452-2013
Class II · Moderate risk

Budesonide

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Terminated Sterility / contamination Franck's Lab Inc., d.b.a. Franck's Compounding Lab D-1469-2012
Class II · Moderate risk

Tobramycin 1.4%

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Terminated Sterility / contamination Franck's Lab Inc., d.b.a. Franck's Compounding Lab D-1627-2012